UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000049025 |
|---|---|
| Receipt number | R000055859 |
| Scientific Title | Retrospective study on endoscopic ultrasonographic aspiration histology for malignant lymphoma |
| Date of disclosure of the study information | 2022/09/27 |
| Last modified on | 2025/01/11 22:57:02 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Retrospective study on endoscopic ultrasonographic aspiration histology for malignant lymphoma
Acronym
EUS-FNAB for malignant lymphoma
Scientific Title
Retrospective study on endoscopic ultrasonographic aspiration histology for malignant lymphoma
Scientific Title:Acronym
EUS-FNAB for malignant lymphoma
Region
| Japan |
Condition
Condition
Malignant Lymphoma
Classification by specialty
| Hepato-biliary-pancreatic medicine |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To clarify the success factors of endoscopic ultrasonography fine-needle aspiration biopsy for malignant lymphoma
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Lesion size, type diagnosis of malignant lymphoma,
Logistic regression analysis will be performed to determine whether the thickness of the puncture needle, the type of puncture needle, the length of the stroke, the number of sessions at the time of puncture, and the scope position at the time of puncture are the success factors of EUS-FNAB as independent variables.
Key secondary outcomes
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1) Diagnosed with malignant lymphoma by pathological examination between April 2012 and July 2022.
2) Between April 2012 and July 2022, endoscopic ultrasonography-guided fine-needle aspiration histology was performed on the lymph nodes, and we have requested histological examination.
Key exclusion criteria
1) Advanced cancer in other organs
2) Viral disease causing lymphadenopathy such as infectious mononucleosis
3) Sarcoidosis, autoimmune diseases, etc.
Target sample size
50
Research contact person
Name of lead principal investigator
| 1st name | Nobuhiko |
| Middle name | |
| Last name | Fukuba |
Organization
Shimane University
Division name
Gastroenterology
Zip code
693-8501
Address
89-1,Enya-cho, Izumo-shi, Shimane,Japan
TEL
+081-0853-23-2190
fnat98@yahoo.co.jp
Public contact
Name of contact person
| 1st name | Nobuhiko |
| Middle name | |
| Last name | Fukuba |
Organization
Shimane University
Division name
Gastroenterology
Zip code
693-8501
Address
89-1,Enya-cho, Izumo-shi, Shimane,Japan
TEL
0853-20-2190
Homepage URL
fnat98@yahoo.co.jp
Sponsor or person
Institute
Shimane University
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Medical Research Ethics Committee, Shimane University Faculty of Medicine
Address
89-1,Enya-cho, Izumo-shi, Shimane,Japan
Tel
0853-20-2515
kenkyu@med.shimane-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2022 | Year | 09 | Month | 27 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2022 | Year | 09 | Month | 28 | Day |
Date of IRB
| 2020 | Year | 09 | Month | 30 | Day |
Anticipated trial start date
| 2022 | Year | 10 | Month | 01 | Day |
Last follow-up date
| 2023 | Year | 09 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
None
Management information
Registered date
| 2022 | Year | 09 | Month | 26 | Day |
Last modified on
| 2025 | Year | 01 | Month | 11 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055859
